Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT02539459
Title Sporadic Angiomyolipomas (AMLs) Growth Kinetics While on Everolimus
Acronym SAGE
Recruitment Terminated
Gender both
Phase Phase II
Variant Requirements No
Sponsors Fox Chase Cancer Center
Indications
Therapies
Age Groups: adult
Covered Countries USA

Facility Status City State Zip Country Details
Yale School of Medicine New Haven Connecticut United States Details
Dana Farber Cancer Institute Boston Massachusetts United States Details
Mayo Clinic Rochester Minnesota United States Details
Memorial Sloan Kettering New York New York United States Details
Duke University Health System Durham North Carolina United States Details
Fox Chase Cancer Center Philadelphia Pennsylvania 19111 United States Details
University of Pennsylvania Philadelphia Pennsylvania United States Details
M D Anderson Cancer Center Houston Texas United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field